The management of type 2 diabetes mellitus FOCUS on quality

被引:2
作者
Miser, William F. [1 ]
机构
[1] Ohio State Univ, Coll Med & Publ Hlth, Dept Family Med, Columbus, OH 43201 USA
来源
PRIMARY CARE | 2007年 / 34卷 / 01期
关键词
D O I
10.1016/j.pop.2007.01.001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Diabetes mellitus (DM) is a group of metabolic disorders associated with abnormalities in carbohydrate, lipid, and protein metabolism [1-3]. The common feature of DM-hyperglycemia-is caused by defects in insulin secretion, insulin action (resistance), or both, with resulting long-term damage to various organs and diminished quality of life. The upper limit of normal fasting plasma glucose is 109 mg/dL. Although this number is somewhat arbitrary, values above this level are associated with a progressively greater risk of developing the many micro- and macrovascular complications associated with DM. The American Diabetes Association (ADA) has established three ways in which one can diagnose a patient as having DM (Box 1) [2,4]. Hemoglobin Alc (HbA1c) levels correlate with the average level of blood glucose over the previous I to 3 months [4-6]. Correlation is higher for glucose levels at lunch time than earlier in the day and is higher for glucose levels in the most recent 30 days than from the prior 31 to 120 days [7]. Although useful in monitoring the degree of glycemic control, the ADA currently does not recommend Its use for diagnostic purposes because there is a lack of its standardization among laboratories. Some investigators advocate its use in diagnosing DM, however, especially when performed in centers in which the test has been standardized [4].
引用
收藏
页码:1 / +
页数:39
相关论文
共 50 条
  • [21] Sulfonylurea treatment of type 2 diabetes mellitus: Focus on glimepiride
    Korytkowski, MT
    PHARMACOTHERAPY, 2004, 24 (05): : 606 - 620
  • [22] Focus on migrants with type 2 diabetes mellitus in European Countries
    Testa, Roberto
    Bonfigli, Anna Rita
    Genovese, Stefano
    Ceriello, Antonio
    INTERNAL AND EMERGENCY MEDICINE, 2016, 11 (03) : 319 - 326
  • [23] Weight Management in Type 2 Diabetes Mellitus
    Siram, Amulya T.
    Yanagisawa, Robert
    Skamagas, Maria
    MOUNT SINAI JOURNAL OF MEDICINE, 2010, 77 (05): : 533 - 548
  • [24] THE FOCUS ON THE PROFESSIONAL GLUCOCARDIOMONITORING AT THE PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Chernikova, N.
    Kamynina, L.
    Ametov, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A210 - A211
  • [25] Glycemic Management of Type 2 Diabetes Mellitus
    Ismail-Beigi, Faramarz
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (14) : 1319 - 1327
  • [26] Teneligliptin in management of type 2 diabetes mellitus
    Sharma, Surendra Kumar
    Panneerselvam, A.
    Singh, K. P.
    Parmar, Girish
    Gadge, Pradeep
    Swami, Onkar C.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2016, 9 : 251 - 260
  • [27] Cardiovascular Disease Risk of Type 2 Diabetes Mellitus and Metabolic Syndrome: Focus on Aggressive Management of Dyslipidemia
    Falko, James M.
    Moser, Robert J.
    Meis, Sophia B.
    Caulin-Glaser, Teresa
    CURRENT DIABETES REVIEWS, 2005, 1 (02) : 127 - 135
  • [28] QUALITY OF SLEEP IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Alemohammad, Z. B.
    Khajeh-Mehrizi, A.
    Sadeghniiat-Haghighi, K.
    Mohajeri-Tehrani, M. R.
    Larijani, B.
    SLEEP MEDICINE, 2017, 40 : E9 - E9
  • [29] Quality of life in patients with type 2 diabetes mellitus
    Porojan, M.
    Poanta, L.
    Dumitrascu, D. L.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2014, 76 (06) : 512 - 512
  • [30] SLEEP DURATION AND QUALITY IN TYPE 2 DIABETES MELLITUS
    Donjacour, C.
    Hazewinkel, A.
    Cessie, S. L.
    Overeem, S.
    Lammers, G.
    Pijl, H.
    SLEEP, 2009, 32 : A145 - A146